Top news of the week: 01.12.2021.
Companies And Industries
FDA Action Alert: Legend & Janssen, Merck & Ridgeback, Amryt, BeyondSpring and More
The U.S. Food and Drug Administration has a very busy calendar for the end of November and beginning of December. Here’s a look.
Omicron Variant has Vaccine Makers Moving Fast and More COVID News
Omicron has caused the U.S. to install travel bans against several South African countries while vaccine makers rush to test their vaccines against it. For that news and more, continue ...
Clinical Catch-Up: November 22-26
Thanksgiving week was marked by numerous clinical trial announcements. Here’s a look.
Promising Signals Emerge from Two Phase II Cancer Studies
Two biopharma companies developing therapeutics in the oncology space begin the week with strong signals in Phase II.
Gene-Based Therapy for Rare Skin Disease Succeeds in Phase III
Results from its GEM-3 trial on VYJUVEK demonstrated statistical significance in its ability to promote complete wound healing within six months compared to a placebo.
Boston Neighbors Net $256 Million for Treg and Allosteric Therapies
Quell Therapeutics scooped up $156 million in a Series B round this week. The company utilizes regulatory T cells to treat a variety of autoimmune and inflammatory diseases.
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a
Sony Biotechnology Virtual Summit 2021
Join us at the 2021 Sony Biotechnology Virtual Summit to hear about the latest innovations using Sony cell sorting and cell analysis platforms. Let us show you how the Sony instrument system